Park Ha Biological Technology is trading 5.15% higher at $2.65, with no verified catalyst identified.

  • No verified company announcement, filing, earnings release, or other clear catalyst was identified for September 23, 2026.
  • Recent securities-class-action reminders remain the main coverage, but do not establish causation.
  • The broader market and biotechnology sector are declining, so they do not explain the gain.